Streamlining processes like trial site selection and FDA documentation can make a meaningful difference in development timelines.
This is the second Edition of the ‘Insights in Pathology’ series. You can find the 2021 volume herePathology, a cornerstone of medical science, has witnessed remarkable advancements in recent years, ...
Amber Hill spent 14 years as a medical researcher. She didn't mind the work, but there was one thing she consistently hated: ...
SARS-CoV-2—initially thought of as an acute respiratory virus—can lead to post-COVID-19 condition (also known as long COVID), a chronic multisystemic illness that develops in some people who have been ...
Just one year after introducing the world’s first burn nursing specialty certification, the Board of Certification for Emergency Nursing (BCEN) proudly reports that nearly 500 nurses in both civilian ...
Compass Pathways' latest update reveals extended trial timelines, staff cuts, and financial concerns, raising questions about ...
Immunis, Inc., a clinical-stage biotech developing novel secretomes for age-related diseases and immune dysfunction, has ...
Multiple sclerosis (MS) is a debilitating disease of the brain and spinal cord that impacts millions worldwide.
AZoLifeSciences on MSN2d
Novel Approach to Isolating and Quantifying EV Cargo for Disease DiagnosisParkinson's disease (PD) and Alzheimer's disease (AD) are examples of brain illnesses that begin to develop in patients far ...
The path from a scientist’s initial idea to a new medicine that can save lives is a complex and often lengthy process. It ...
Lonza’s innovative continuous flow technology and mini-monoplant approach are transforming early-phase drug development. How ...
The initial phases of their research, involving experiments with mice and brain models, might take several years, Tesar said.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback